Life Sciences

Pharmaceutical, medical device and biotechnology companies remain under pressure to navigate ever-changing regulations while justifying product value and improving health outcomes.

Featured Insights

  • Biopharmaceutical Firm Increases Efficiency and Global Compliance with a Centralized Risk Management System

    Read More

    To minimize compliance costs and inefficiencies across global teams, one biopharmaceutical firm implemented Orbit, a centralized drug safety commitment platform.

  • Launch Excellence: Why So Elusive?

    Read More

    Product launches are inherently optimistic occasions for companies, representing opportunities to market new products and generate fresh sources of revenue.

View All

Experts